PDS Biotechnology (PDSB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The CBI on Monday sought time from a Delhi court to verify the status of various accused persons in the alleged land-for-jobs ...